To evaluate, in asymptomatic and symptomatic participants with peripheral arterial disease,
the feasibility of recruitment and adherence, efficacy and safety of HDL-C raising along with
effective control of LDL-C levels, antioxidant therapy, antithrombotic therapy, and their
combinations.
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
National Heart, Lung, and Blood Institute (NHLBI)
Treatments:
Beta Carotene Carotenoids Pravastatin Vitamin E Vitamins Warfarin
Criteria
Men and women with symptomatic or asymptomatic peripheral arterial disease.